Aurinia Pharmaceuticals Inc (AUPH)

AUPH (NASDAQ:Drugs) EQUITY
$6.36
neg -0.23
-3.49%
Today's Range: 6.33 - 6.57 | AUPH Avg Daily Volume: 9,474,900
Last Update: 05/26/17 - 4:00 PM EDT
Volume: 2,655,580
YTD Performance: 213.81%
Open: $6.54
Previous Close: $6.59
52 Week Range: $1.42 - $4.30
Oustanding Shares: 83,272,293
Market Cap: 548,764,411
6-Month Chart
TheStreet Ratings Grade for AUPH
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.22 1.22 1.26 1.26
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -4.54
Price Earnings Comparisons:
AUPH Sector Avg. S&P 500
-4.54 0.00 29.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
77.15% 151.38% 98.22%
GROWTH 12 Mo 3 Yr CAGR
Revenue -26.40 -0.80 -0.43
Net Income 0.00 8.20 0.00
EPS 0.00 0.70 0.00
Earnings for AUPH:
EBITDA -0.02B
Revenue 0.00B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $-0.12 $-0.13 $-0.95 $-0.57
Number of Analysts 4 4 5 4
High Estimate $-0.11 $-0.11 $-0.55 $-0.43
Low Estimate $-0.13 $-0.14 $-1.14 $-0.70
Prior Year $-0.14 $-0.19 $-0.69 $-0.95
Growth Rate (Year over Year) 12.50% 34.21% -37.10% 39.48%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Without strength in the big-cap leaders, this market is tough to trade.
Brief selloff greets Trump statement on breaking up banks.
Trading in an incremental manner can be particularly important in dealing with earnings reports.
Bulls can't build as headlines start to matter more.
If you want to trade, you have to maintain short timeframes and be ready to flip.
But it is not without some pain.
Great traders will bide their time in this environment and then move big and fast when the conditions are right.
But what will be most important is whether support stays strong and the buyers show interest in the afternoon.
Why not buy something and try to make some money rather than waste time predicting how this will all come to an ugly end?
Biotech companies show more energy than the rest of the market Monday.

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.